How big is the rabies immune globulin human market?

Q: How big is the rabies immune globulin human market?

According to QYResearchs new survey global Rabies Immune Globulin Human market is projected to reach US 1973.9 million in 2029 increasing from US 1500 million in 2022 with the CAGR of 4.0 during the period of 2023 to 2029.

BUY CHAPTERS

Global Rabies Immune Globulin (Human) Market Research Report 2023

Code: QYRE-Auto-17R15045

Report

July 2023

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

World Health Organization

Bio Products Laboratory

Sichuan Yuanda Shuyang

Kedrion Biopharma

Congruent Pharmachem

hualanbio

Rabies Immune Globulin (Human) Market Size

According to QYResearch’s new survey, global Rabies Immune Globulin (Human) market is projected to reach US$ 1973.9 million in 2029, increasing from US$ 1500 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2029.

Rabies Immune Globulin (Human) Market

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rabies Immune Globulin (Human) market research.

The market for Rabies Immune Globulin (Human) is primarily driven by the incidence of rabies in different regions of the world. According to the World Health Organization, rabies is present in more than 150 countries, with an estimated 59,000 human deaths annually. The majority of these deaths occur in Asia and Africa, where access to post-exposure prophylaxis may be limited.

In addition, the market for Rabies Immune Globulin (Human) is also influenced by government policies and regulations related to rabies prevention and control. Many countries have established national vaccination programs and guidelines for post-exposure prophylaxis, which may include the use of Rabies Immune Globulin (Human).

Overall, the market for Rabies Immune Globulin (Human) is expected to continue to grow as awareness of rabies and the importance of post-exposure prophylaxis increases, particularly in regions with high incidence of the disease.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rabies Immune Globulin (Human) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Rabies Immune Globulin (Human) Market Report

Report Metric	Details
Report Name	Rabies Immune Globulin (Human) Market
Accounted market size in 2022	US$ 1500 million
Forecasted market size in 2029	US$ 1973.9 million
CAGR	4.0%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	HyperRAB S/D KEDRAB
Segment by Application	Clinic Hospital
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL Behring, Grifols, Sanofi, Kamada, Bharat Serum, Bio Products Laboratory, Shanghai RAAS, Weiguang Bio, Shuanglin Bio, CBPO, CNBG, Sichuan Yuanda Shuyang, Kedrion Biopharma, Congruent Pharmachem, hualanbio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Rabies Immune Globulin (Human) Market market growing?

Ans: The Rabies Immune Globulin (Human) Market market witnessing a CAGR of 4.0% during the forecast period 2023-2029.

What is the Rabies Immune Globulin (Human) Market market size in 2029?

Ans: According to QYResearch’s new survey, global Rabies Immune Globulin (Human) market is projected to reach US$ 1973.9 million in 2029, increasing from US$ 1500 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2029.

1 Rabies Immune Globulin (Human) Market Overview

1.1 Product Overview and Scope of Rabies Immune Globulin (Human)

1.2 Rabies Immune Globulin (Human) Segment by Type

1.2.1 Global Rabies Immune Globulin (Human) Market Value Comparison by Type (2023-2029)

1.2.2 HyperRAB S/D

1.2.3 KEDRAB

1.3 Rabies Immune Globulin (Human) Segment by Application

1.3.1 Global Rabies Immune Globulin (Human) Market Value by Application: (2023-2029)

1.3.2 Clinic

1.3.3 Hospital

1.4 Global Rabies Immune Globulin (Human) Market Size Estimates and Forecasts

1.4.1 Global Rabies Immune Globulin (Human) Revenue 2018-2029

1.4.2 Global Rabies Immune Globulin (Human) Sales 2018-2029

1.4.3 Global Rabies Immune Globulin (Human) Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2 Rabies Immune Globulin (Human) Market Competition by Manufacturers

2.1 Global Rabies Immune Globulin (Human) Sales Market Share by Manufacturers (2018-2023)

2.2 Global Rabies Immune Globulin (Human) Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Rabies Immune Globulin (Human) Average Price by Manufacturers (2018-2023)

2.4 Global Rabies Immune Globulin (Human) Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Rabies Immune Globulin (Human), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Rabies Immune Globulin (Human), Product Type & Application

2.7 Rabies Immune Globulin (Human) Market Competitive Situation and Trends

2.7.1 Rabies Immune Globulin (Human) Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Rabies Immune Globulin (Human) Players Market Share by Revenue

2.7.3 Global Rabies Immune Globulin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Rabies Immune Globulin (Human) Retrospective Market Scenario by Region

3.1 Global Rabies Immune Globulin (Human) Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Rabies Immune Globulin (Human) Global Rabies Immune Globulin (Human) Sales by Region: 2018-2029

3.2.1 Global Rabies Immune Globulin (Human) Sales by Region: 2018-2023

3.2.2 Global Rabies Immune Globulin (Human) Sales by Region: 2024-2029

3.3 Global Rabies Immune Globulin (Human) Global Rabies Immune Globulin (Human) Revenue by Region: 2018-2029

3.3.1 Global Rabies Immune Globulin (Human) Revenue by Region: 2018-2023

3.3.2 Global Rabies Immune Globulin (Human) Revenue by Region: 2024-2029

3.4 North America Rabies Immune Globulin (Human) Market Facts & Figures by Country

3.4.1 North America Rabies Immune Globulin (Human) Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Rabies Immune Globulin (Human) Sales by Country (2018-2029)

3.4.3 North America Rabies Immune Globulin (Human) Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Rabies Immune Globulin (Human) Market Facts & Figures by Country

3.5.1 Europe Rabies Immune Globulin (Human) Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Rabies Immune Globulin (Human) Sales by Country (2018-2029)

3.5.3 Europe Rabies Immune Globulin (Human) Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rabies Immune Globulin (Human) Market Facts & Figures by Country

3.6.1 Asia Pacific Rabies Immune Globulin (Human) Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Rabies Immune Globulin (Human) Sales by Country (2018-2029)

3.6.3 Asia Pacific Rabies Immune Globulin (Human) Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Rabies Immune Globulin (Human) Market Facts & Figures by Country

3.7.1 Latin America Rabies Immune Globulin (Human) Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Rabies Immune Globulin (Human) Sales by Country (2018-2029)

3.7.3 Latin America Rabies Immune Globulin (Human) Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Rabies Immune Globulin (Human) Market Facts & Figures by Country

3.8.1 Middle East and Africa Rabies Immune Globulin (Human) Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Rabies Immune Globulin (Human) Sales by Country (2018-2029)

3.8.3 Middle East and Africa Rabies Immune Globulin (Human) Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Rabies Immune Globulin (Human) Sales by Type (2018-2029)

4.1.1 Global Rabies Immune Globulin (Human) Sales by Type (2018-2023)

4.1.2 Global Rabies Immune Globulin (Human) Sales by Type (2024-2029)

4.1.3 Global Rabies Immune Globulin (Human) Sales Market Share by Type (2018-2029)

4.2 Global Rabies Immune Globulin (Human) Revenue by Type (2018-2029)

4.2.1 Global Rabies Immune Globulin (Human) Revenue by Type (2018-2023)

4.2.2 Global Rabies Immune Globulin (Human) Revenue by Type (2024-2029)

4.2.3 Global Rabies Immune Globulin (Human) Revenue Market Share by Type (2018-2029)

4.3 Global Rabies Immune Globulin (Human) Price by Type (2018-2029)

5 Segment by Application

5.1 Global Rabies Immune Globulin (Human) Sales by Application (2018-2029)

5.1.1 Global Rabies Immune Globulin (Human) Sales by Application (2018-2023)

5.1.2 Global Rabies Immune Globulin (Human) Sales by Application (2024-2029)

5.1.3 Global Rabies Immune Globulin (Human) Sales Market Share by Application (2018-2029)

5.2 Global Rabies Immune Globulin (Human) Revenue by Application (2018-2029)

5.2.1 Global Rabies Immune Globulin (Human) Revenue by Application (2018-2023)

5.2.2 Global Rabies Immune Globulin (Human) Revenue by Application (2024-2029)

5.2.3 Global Rabies Immune Globulin (Human) Revenue Market Share by Application (2018-2029)

5.3 Global Rabies Immune Globulin (Human) Price by Application (2018-2029)

6 Key Companies Profiled

6.1 CSL Behring

6.1.1 CSL Behring Corporation Information

6.1.2 CSL Behring Description and Business Overview

6.1.3 CSL Behring Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.1.4 CSL Behring Rabies Immune Globulin (Human) Product Portfolio

6.1.5 CSL Behring Recent Developments/Updates

6.2 Grifols

6.2.1 Grifols Corporation Information

6.2.2 Grifols Description and Business Overview

6.2.3 Grifols Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Grifols Rabies Immune Globulin (Human) Product Portfolio

6.2.5 Grifols Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Corporation Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Sanofi Rabies Immune Globulin (Human) Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 Kamada

6.4.1 Kamada Corporation Information

6.4.2 Kamada Description and Business Overview

6.4.3 Kamada Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Kamada Rabies Immune Globulin (Human) Product Portfolio

6.4.5 Kamada Recent Developments/Updates

6.5 Bharat Serum

6.5.1 Bharat Serum Corporation Information

6.5.2 Bharat Serum Description and Business Overview

6.5.3 Bharat Serum Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Bharat Serum Rabies Immune Globulin (Human) Product Portfolio

6.5.5 Bharat Serum Recent Developments/Updates

6.6 Bio Products Laboratory

6.6.1 Bio Products Laboratory Corporation Information

6.6.2 Bio Products Laboratory Description and Business Overview

6.6.3 Bio Products Laboratory Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Bio Products Laboratory Rabies Immune Globulin (Human) Product Portfolio

6.6.5 Bio Products Laboratory Recent Developments/Updates

6.7 Shanghai RAAS

6.6.1 Shanghai RAAS Corporation Information

6.6.2 Shanghai RAAS Description and Business Overview

6.6.3 Shanghai RAAS Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Shanghai RAAS Rabies Immune Globulin (Human) Product Portfolio

6.7.5 Shanghai RAAS Recent Developments/Updates

6.8 Weiguang Bio

6.8.1 Weiguang Bio Corporation Information

6.8.2 Weiguang Bio Description and Business Overview

6.8.3 Weiguang Bio Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Weiguang Bio Rabies Immune Globulin (Human) Product Portfolio

6.8.5 Weiguang Bio Recent Developments/Updates

6.9 Shuanglin Bio

6.9.1 Shuanglin Bio Corporation Information

6.9.2 Shuanglin Bio Description and Business Overview

6.9.3 Shuanglin Bio Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Shuanglin Bio Rabies Immune Globulin (Human) Product Portfolio

6.9.5 Shuanglin Bio Recent Developments/Updates

6.10 CBPO

6.10.1 CBPO Corporation Information

6.10.2 CBPO Description and Business Overview

6.10.3 CBPO Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.10.4 CBPO Rabies Immune Globulin (Human) Product Portfolio

6.10.5 CBPO Recent Developments/Updates

6.11 CNBG

6.11.1 CNBG Corporation Information

6.11.2 CNBG Rabies Immune Globulin (Human) Description and Business Overview

6.11.3 CNBG Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.11.4 CNBG Rabies Immune Globulin (Human) Product Portfolio

6.11.5 CNBG Recent Developments/Updates

6.12 Sichuan Yuanda Shuyang

6.12.1 Sichuan Yuanda Shuyang Corporation Information

6.12.2 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Description and Business Overview

6.12.3 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Portfolio

6.12.5 Sichuan Yuanda Shuyang Recent Developments/Updates

6.13 Kedrion Biopharma

6.13.1 Kedrion Biopharma Corporation Information

6.13.2 Kedrion Biopharma Rabies Immune Globulin (Human) Description and Business Overview

6.13.3 Kedrion Biopharma Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Kedrion Biopharma Rabies Immune Globulin (Human) Product Portfolio

6.13.5 Kedrion Biopharma Recent Developments/Updates

6.14 Congruent Pharmachem

6.14.1 Congruent Pharmachem Corporation Information

6.14.2 Congruent Pharmachem Rabies Immune Globulin (Human) Description and Business Overview

6.14.3 Congruent Pharmachem Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Congruent Pharmachem Rabies Immune Globulin (Human) Product Portfolio

6.14.5 Congruent Pharmachem Recent Developments/Updates

6.15 hualanbio

6.15.1 hualanbio Corporation Information

6.15.2 hualanbio Rabies Immune Globulin (Human) Description and Business Overview

6.15.3 hualanbio Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2018-2023)

6.15.4 hualanbio Rabies Immune Globulin (Human) Product Portfolio

6.15.5 hualanbio Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rabies Immune Globulin (Human) Industry Chain Analysis

7.2 Rabies Immune Globulin (Human) Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rabies Immune Globulin (Human) Production Mode & Process

7.4 Rabies Immune Globulin (Human) Sales and Marketing

7.4.1 Rabies Immune Globulin (Human) Sales Channels

7.4.2 Rabies Immune Globulin (Human) Distributors

7.5 Rabies Immune Globulin (Human) Customers

8 Rabies Immune Globulin (Human) Market Dynamics

8.1 Rabies Immune Globulin (Human) Industry Trends

8.2 Rabies Immune Globulin (Human) Market Drivers

8.3 Rabies Immune Globulin (Human) Market Challenges

8.4 Rabies Immune Globulin (Human) Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

World Health Organization

Bio Products Laboratory

Sichuan Yuanda Shuyang

Kedrion Biopharma

Congruent Pharmachem

hualanbio

List of Tables

Table 1. Global Rabies Immune Globulin (Human) Market Value Comparison by Type (2023-2029) & (US$ Million)

Table 2. Global Rabies Immune Globulin (Human) Market Value Comparison by Application (2023-2029) & (US$ Million)

Table 3. Global Rabies Immune Globulin (Human) Market Competitive Situation by Manufacturers in 2022

Table 4. Global Rabies Immune Globulin (Human) Sales (K Units) of Key Manufacturers (2018-2023)

Table 5. Global Rabies Immune Globulin (Human) Sales Market Share by Manufacturers (2018-2023)

Table 6. Global Rabies Immune Globulin (Human) Revenue (US$ Million) by Manufacturers (2018-2023)

Table 7. Global Rabies Immune Globulin (Human) Revenue Share by Manufacturers (2018-2023)

Table 8. Global Market Rabies Immune Globulin (Human) Average Price (US$/Unit) of Key Manufacturers (2018-2023)

Table 9. Global Key Players of Rabies Immune Globulin (Human), Industry Ranking, 2021 VS 2022 VS 2023

Table 10. Global Key Manufacturers of Rabies Immune Globulin (Human), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Rabies Immune Globulin (Human), Product Type & Application

Table 12. Global Key Manufacturers of Rabies Immune Globulin (Human), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rabies Immune Globulin (Human) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Human) as of 2022)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rabies Immune Globulin (Human) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 17. Global Rabies Immune Globulin (Human) Sales by Region (2018-2023) & (K Units)

Table 18. Global Rabies Immune Globulin (Human) Sales Market Share by Region (2018-2023)

Table 19. Global Rabies Immune Globulin (Human) Sales by Region (2024-2029) & (K Units)

Table 20. Global Rabies Immune Globulin (Human) Sales Market Share by Region (2024-2029)

Table 21. Global Rabies Immune Globulin (Human) Revenue by Region (2018-2023) & (US$ Million)

Table 22. Global Rabies Immune Globulin (Human) Revenue Market Share by Region (2018-2023)

Table 23. Global Rabies Immune Globulin (Human) Revenue by Region (2024-2029) & (US$ Million)

Table 24. Global Rabies Immune Globulin (Human) Revenue Market Share by Region (2024-2029)

Table 25. North America Rabies Immune Globulin (Human) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 26. North America Rabies Immune Globulin (Human) Sales by Country (2018-2023) & (K Units)

Table 27. North America Rabies Immune Globulin (Human) Sales by Country (2024-2029) & (K Units)

Table 28. North America Rabies Immune Globulin (Human) Revenue by Country (2018-2023) & (US$ Million)

Table 29. North America Rabies Immune Globulin (Human) Revenue by Country (2024-2029) & (US$ Million)

Table 30. Europe Rabies Immune Globulin (Human) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 31. Europe Rabies Immune Globulin (Human) Sales by Country (2018-2023) & (K Units)

Table 32. Europe Rabies Immune Globulin (Human) Sales by Country (2024-2029) & (K Units)

Table 33. Europe Rabies Immune Globulin (Human) Revenue by Country (2018-2023) & (US$ Million)

Table 34. Europe Rabies Immune Globulin (Human) Revenue by Country (2024-2029) & (US$ Million)

Table 35. Asia Pacific Rabies Immune Globulin (Human) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 36. Asia Pacific Rabies Immune Globulin (Human) Sales by Region (2018-2023) & (K Units)

Table 37. Asia Pacific Rabies Immune Globulin (Human) Sales by Region (2024-2029) & (K Units)

Table 38. Asia Pacific Rabies Immune Globulin (Human) Revenue by Region (2018-2023) & (US$ Million)

Table 39. Asia Pacific Rabies Immune Globulin (Human) Revenue by Region (2024-2029) & (US$ Million)

Table 40. Latin America Rabies Immune Globulin (Human) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 41. Latin America Rabies Immune Globulin (Human) Sales by Country (2018-2023) & (K Units)

Table 42. Latin America Rabies Immune Globulin (Human) Sales by Country (2024-2029) & (K Units)

Table 43. Latin America Rabies Immune Globulin (Human) Revenue by Country (2018-2023) & (US$ Million)

Table 44. Latin America Rabies Immune Globulin (Human) Revenue by Country (2024-2029) & (US$ Million)

Table 45. Middle East & Africa Rabies Immune Globulin (Human) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 46. Middle East & Africa Rabies Immune Globulin (Human) Sales by Country (2018-2023) & (K Units)

Table 47. Middle East & Africa Rabies Immune Globulin (Human) Sales by Country (2024-2029) & (K Units)

Table 48. Middle East & Africa Rabies Immune Globulin (Human) Revenue by Country (2018-2023) & (US$ Million)

Table 49. Middle East & Africa Rabies Immune Globulin (Human) Revenue by Country (2024-2029) & (US$ Million)

Table 50. Global Rabies Immune Globulin (Human) Sales (K Units) by Type (2018-2023)

Table 51. Global Rabies Immune Globulin (Human) Sales (K Units) by Type (2024-2029)

Table 52. Global Rabies Immune Globulin (Human) Sales Market Share by Type (2018-2023)

Table 53. Global Rabies Immune Globulin (Human) Sales Market Share by Type (2024-2029)

Table 54. Global Rabies Immune Globulin (Human) Revenue (US$ Million) by Type (2018-2023)

Table 55. Global Rabies Immune Globulin (Human) Revenue (US$ Million) by Type (2024-2029)

Table 56. Global Rabies Immune Globulin (Human) Revenue Market Share by Type (2018-2023)

Table 57. Global Rabies Immune Globulin (Human) Revenue Market Share by Type (2024-2029)

Table 58. Global Rabies Immune Globulin (Human) Price (US$/Unit) by Type (2018-2023)

Table 59. Global Rabies Immune Globulin (Human) Price (US$/Unit) by Type (2024-2029)

Table 60. Global Rabies Immune Globulin (Human) Sales (K Units) by Application (2018-2023)

Table 61. Global Rabies Immune Globulin (Human) Sales (K Units) by Application (2024-2029)

Table 62. Global Rabies Immune Globulin (Human) Sales Market Share by Application (2018-2023)

Table 63. Global Rabies Immune Globulin (Human) Sales Market Share by Application (2024-2029)

Table 64. Global Rabies Immune Globulin (Human) Revenue (US$ Million) by Application (2018-2023)

Table 65. Global Rabies Immune Globulin (Human) Revenue (US$ Million) by Application (2024-2029)

Table 66. Global Rabies Immune Globulin (Human) Revenue Market Share by Application (2018-2023)

Table 67. Global Rabies Immune Globulin (Human) Revenue Market Share by Application (2024-2029)

Table 68. Global Rabies Immune Globulin (Human) Price (US$/Unit) by Application (2018-2023)

Table 69. Global Rabies Immune Globulin (Human) Price (US$/Unit) by Application (2024-2029)

Table 70. CSL Behring Corporation Information

Table 71. CSL Behring Description and Business Overview

Table 72. CSL Behring Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 73. CSL Behring Rabies Immune Globulin (Human) Product

Table 74. CSL Behring Recent Developments/Updates

Table 75. Grifols Corporation Information

Table 76. Grifols Description and Business Overview

Table 77. Grifols Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 78. Grifols Rabies Immune Globulin (Human) Product

Table 79. Grifols Recent Developments/Updates

Table 80. Sanofi Corporation Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 83. Sanofi Rabies Immune Globulin (Human) Product

Table 84. Sanofi Recent Developments/Updates

Table 85. Kamada Corporation Information

Table 86. Kamada Description and Business Overview

Table 87. Kamada Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 88. Kamada Rabies Immune Globulin (Human) Product

Table 89. Kamada Recent Developments/Updates

Table 90. Bharat Serum Corporation Information

Table 91. Bharat Serum Description and Business Overview

Table 92. Bharat Serum Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 93. Bharat Serum Rabies Immune Globulin (Human) Product

Table 94. Bharat Serum Recent Developments/Updates

Table 95. Bio Products Laboratory Corporation Information

Table 96. Bio Products Laboratory Description and Business Overview

Table 97. Bio Products Laboratory Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 98. Bio Products Laboratory Rabies Immune Globulin (Human) Product

Table 99. Bio Products Laboratory Recent Developments/Updates

Table 100. Shanghai RAAS Corporation Information

Table 101. Shanghai RAAS Description and Business Overview

Table 102. Shanghai RAAS Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 103. Shanghai RAAS Rabies Immune Globulin (Human) Product

Table 104. Shanghai RAAS Recent Developments/Updates

Table 105. Weiguang Bio Corporation Information

Table 106. Weiguang Bio Description and Business Overview

Table 107. Weiguang Bio Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 108. Weiguang Bio Rabies Immune Globulin (Human) Product

Table 109. Weiguang Bio Recent Developments/Updates

Table 110. Shuanglin Bio Corporation Information

Table 111. Shuanglin Bio Description and Business Overview

Table 112. Shuanglin Bio Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 113. Shuanglin Bio Rabies Immune Globulin (Human) Product

Table 114. Shuanglin Bio Recent Developments/Updates

Table 115. CBPO Corporation Information

Table 116. CBPO Description and Business Overview

Table 117. CBPO Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 118. CBPO Rabies Immune Globulin (Human) Product

Table 119. CBPO Recent Developments/Updates

Table 120. CNBG Corporation Information

Table 121. CNBG Description and Business Overview

Table 122. CNBG Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 123. CNBG Rabies Immune Globulin (Human) Product

Table 124. CNBG Recent Developments/Updates

Table 125. Sichuan Yuanda Shuyang Corporation Information

Table 126. Sichuan Yuanda Shuyang Description and Business Overview

Table 127. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 128. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product

Table 129. Sichuan Yuanda Shuyang Recent Developments/Updates

Table 130. Kedrion Biopharma Corporation Information

Table 131. Kedrion Biopharma Description and Business Overview

Table 132. Kedrion Biopharma Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 133. Kedrion Biopharma Rabies Immune Globulin (Human) Product

Table 134. Kedrion Biopharma Recent Developments/Updates

Table 135. Congruent Pharmachem Corporation Information

Table 136. Congruent Pharmachem Description and Business Overview

Table 137. Congruent Pharmachem Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 138. Congruent Pharmachem Rabies Immune Globulin (Human) Product

Table 139. Congruent Pharmachem Recent Developments/Updates

Table 140. hualanbio Corporation Information

Table 141. hualanbio Description and Business Overview

Table 142. hualanbio Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 143. hualanbio Rabies Immune Globulin (Human) Product

Table 144. hualanbio Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Rabies Immune Globulin (Human) Distributors List

Table 148. Rabies Immune Globulin (Human) Customers List

Table 149. Rabies Immune Globulin (Human) Market Trends

Table 150. Rabies Immune Globulin (Human) Market Drivers

Table 151. Rabies Immune Globulin (Human) Market Challenges

Table 152. Rabies Immune Globulin (Human) Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Rabies Immune Globulin (Human)

Figure 2. Global Rabies Immune Globulin (Human) Market Value Comparison by Type (2023-2029) & (US$ Million)

Figure 3. Global Rabies Immune Globulin (Human) Market Share by Type in 2022 & 2029

Figure 4. HyperRAB S/D Product Picture

Figure 5. KEDRAB Product Picture

Figure 6. Global Rabies Immune Globulin (Human) Market Value Comparison by Application (2023-2029) & (US$ Million)

Figure 7. Global Rabies Immune Globulin (Human) Market Share by Application in 2022 & 2029

Figure 8. Clinic

Figure 9. Hospital

Figure 10. Global Rabies Immune Globulin (Human) Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 11. Global Rabies Immune Globulin (Human) Market Size (2018-2029) & (US$ Million)

Figure 12. Global Rabies Immune Globulin (Human) Sales (2018-2029) & (K Units)

Figure 13. Global Rabies Immune Globulin (Human) Average Price (US$/Unit) & (2018-2029)

Figure 14. Rabies Immune Globulin (Human) Report Years Considered

Figure 15. Rabies Immune Globulin (Human) Sales Share by Manufacturers in 2022

Figure 16. Global Rabies Immune Globulin (Human) Revenue Share by Manufacturers in 2022

Figure 17. The Global 5 and 10 Largest Rabies Immune Globulin (Human) Players: Market Share by Revenue in 2022

Figure 18. Rabies Immune Globulin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 19. Global Rabies Immune Globulin (Human) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Figure 20. North America Rabies Immune Globulin (Human) Sales Market Share by Country (2018-2029)

Figure 21. North America Rabies Immune Globulin (Human) Revenue Market Share by Country (2018-2029)

Figure 22. United States Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 23. Canada Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 24. Europe Rabies Immune Globulin (Human) Sales Market Share by Country (2018-2029)

Figure 25. Europe Rabies Immune Globulin (Human) Revenue Market Share by Country (2018-2029)

Figure 26. Germany Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 27. France Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 28. U.K. Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 29. Italy Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 30. Russia Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 31. Asia Pacific Rabies Immune Globulin (Human) Sales Market Share by Region (2018-2029)

Figure 32. Asia Pacific Rabies Immune Globulin (Human) Revenue Market Share by Region (2018-2029)

Figure 33. China Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 34. Japan Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 35. South Korea Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 36. India Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 37. Australia Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 38. China Taiwan Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 39. Southeast Asia Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 40. Latin America Rabies Immune Globulin (Human) Sales Market Share by Country (2018-2029)

Figure 41. Latin America Rabies Immune Globulin (Human) Revenue Market Share by Country (2018-2029)

Figure 42. Mexico Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 43. Brazil Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 44. Argentina Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 45. Colombia Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 46. Middle East & Africa Rabies Immune Globulin (Human) Sales Market Share by Country (2018-2029)

Figure 47. Middle East & Africa Rabies Immune Globulin (Human) Revenue Market Share by Country (2018-2029)

Figure 48. Turkey Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 49. Saudi Arabia Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 50. UAE Rabies Immune Globulin (Human) Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 51. Global Sales Market Share of Rabies Immune Globulin (Human) by Type (2018-2029)

Figure 52. Global Revenue Market Share of Rabies Immune Globulin (Human) by Type (2018-2029)

Figure 53. Global Rabies Immune Globulin (Human) Price (US$/Unit) by Type (2018-2029)

Figure 54. Global Sales Market Share of Rabies Immune Globulin (Human) by Application (2018-2029)

Figure 55. Global Revenue Market Share of Rabies Immune Globulin (Human) by Application (2018-2029)

Figure 56. Global Rabies Immune Globulin (Human) Price (US$/Unit) by Application (2018-2029)

Figure 57. Rabies Immune Globulin (Human) Value Chain

Figure 58. Rabies Immune Globulin (Human) Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Rabies Immune Globulin (Human) Market Research Report 2023

Published Date: July 2023

Report Code: QYRE-Auto-17R15045

Global Rabies Immune Globulin (Human) Market Research Report 2023

FEATURED COMPANIES

Rabies Immune Globulin (Human) Market Size

Rabies Immune Globulin (Human) Market

Report Scope

Scope of Rabies Immune Globulin (Human) Market Report

FAQ for this report

How fast is Rabies Immune Globulin (Human) Market market growing?

What is the Rabies Immune Globulin (Human) Market market size in 2029?

FEATURED COMPANIES

RELATED REPORTS